<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>e-sygoing.link — Cancer</title>
  <link>https://e-sygoing.link</link>
  <description>Latest links in the Cancer category</description>
  <language>en-us</language>
  <lastBuildDate>Sun, 24 May 2026 13:53:35 -0400</lastBuildDate>
  <atom:link href="https://e-sygoing.link/rss.php?type=new&amp;cid=87279"
             rel="self" type="application/rss+xml"/>
    <item>
    <title>InterGenetics Inc.</title>
    <link>https://e-sygoing.link/link/5624188-intergenetics-inc</link>
    <description>Company with platform technology, called CombiSNiP, that genetically quantifies an individual&#039;s risk for development, and is involved in pharmacogenetics research on treating breast cancer. Includes corporate overview, directions and contacts in Oklahoma City.</description>
    <pubDate>Wed, 06 May 2026 16:01:56 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624188</guid>
  </item>
    <item>
    <title>Genentech Biooncology</title>
    <link>https://e-sygoing.link/link/5624203-genentech-biooncology</link>
    <description>Resource treatments aimed at chronic management, focusing on anti-angiogenesis, apoptosis, B-cell biology and HER signaling. Includes sections for professionals, customers and patients, with contacts in South San Francisco, California.</description>
    <pubDate>Wed, 15 Apr 2026 13:49:53 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624203</guid>
  </item>
    <item>
    <title>PNP Therapeutics, Inc.</title>
    <link>https://e-sygoing.link/link/5624181-pnp-therapeutics-inc</link>
    <description>Company developing gene therapy system, using the E. coli enzyme, purine nucleoside phosphorylase, to induce suicide in tumor cells. Includes technology background, research, patents, publications, key staff, and contacts in Birmingham, Alabama.</description>
    <pubDate>Wed, 28 Jan 2026 04:43:39 -0500</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624181</guid>
  </item>
    <item>
    <title>Maxim Pharmaceuticals, Inc.</title>
    <link>https://e-sygoing.link/link/5624210-maxim-pharmaceuticals-inc</link>
    <description>Researches and develops therapy products and vaccines for the prevention and treatment of tumors and leukema. Based in San Diego, California. (Nasdaq: MAXM)</description>
    <pubDate>Fri, 02 Jan 2026 09:27:08 -0500</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624210</guid>
  </item>
    <item>
    <title>Aventis Cancer Vaccine Program</title>
    <link>https://e-sygoing.link/link/5624184-aventis-cancer-vaccine-program</link>
    <description>Studying the possibilities of using an immunotherapeutic approach for melanoma, breast and colorectal and tumors. Includes results of clinical research, FAQ, contact form, and profile of research partners in Canada.</description>
    <pubDate>Thu, 09 Oct 2025 20:40:30 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624184</guid>
  </item>
    <item>
    <title>Pivotal BioSciences, Inc.</title>
    <link>https://e-sygoing.link/link/5624195-pivotal-biosciences-inc</link>
    <description>Management and pipeline of cancer therapeutics licensed from the University of Southern California Keck School of Medicine in Los Angeles, California.</description>
    <pubDate>Tue, 19 Aug 2025 15:44:09 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624195</guid>
  </item>
    <item>
    <title>Onyvax Ltd.</title>
    <link>https://e-sygoing.link/link/5624183-onyvax-ltd</link>
    <description>Conducts research and development for marketing cell-based vaccines and human monoclonal antibody against CD55 in tumour cells.  Includes explanation of products in pipeline, and clinical studies in phase II of prostate cancer vaccine at Bournemouth, and their contacts in London, UK.</description>
    <pubDate>Sat, 26 Jul 2025 17:39:38 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624183</guid>
  </item>
    <item>
    <title>Tapestry Pharmaceuticals</title>
    <link>https://e-sygoing.link/link/5624214-tapestry-pharmaceuticals</link>
    <description>Develops, produces and licenses natural products, such as quassinoids and taxanes. Includes introduction to targeted oncology, investment data and profile of company in Boulder, Colorado. (Nasdaq: NPRO)</description>
    <pubDate>Fri, 21 Mar 2025 01:07:38 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624214</guid>
  </item>
    <item>
    <title>Altarex Corp.</title>
    <link>https://e-sygoing.link/link/5624194-altarex-corp</link>
    <description>Focused on photoactivation and multi-epitopic development of foreign antibodies that activate and modulate the immune system for the treatment of ovarian tumors and multiple myeloma. Profile of company, clinic and science, with investor data and contacts at University of Alberta, Edmonton, Canada.</description>
    <pubDate>Sun, 29 Dec 2024 07:45:35 -0500</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624194</guid>
  </item>
    <item>
    <title>CancerVax Corp.</title>
    <link>https://e-sygoing.link/link/5624202-cancervax-corp</link>
    <description>Development and commercialization of vaccines, and treatments, such as telomere homologs and angiogenesis inhibition. Includes product pipeline, clinical trials, corporate profile and contacts in Carlsbad, California.</description>
    <pubDate>Sun, 14 Jul 2024 22:15:04 -0400</pubDate>
    <guid isPermaLink="false">https://e-sygoing.link/go/5624202</guid>
  </item>
  </channel>
</rss>
